Vanderbeeken Y E, Duchateau J, Colletl H, Gregoire M, Desseilles P, Lucas A
Service D'Immunologie Hopital, St. Pierre, Brussels, Belgium.
Immunopharmacol Immunotoxicol. 1990;12(4):679-95. doi: 10.3109/08923979009019684.
The recent immunological literature has described the existence of a retroplacental serum factor being responsible for the downregulation of the MHC Class II antigen expression. In this report, the same property has been found in peripheral maternal serum. The HLA Class II modulating activity is however diminished in the presence of peripheral maternal serum as compared to retroplacental serum suggesting that the IA like inhibiting factor is released at the fetomaternal interface. After a three-day incubation period of unrelated lymphocytes in a maternal serum pool, it was shown that the HLA Dr., the HLA Dp., and more significantly, the HLA Dq. molecules were modulated. When third party lymphocytes were stimulated by Candidine or unrelated mononuclear cells in the presence of retroplacental serum, only the cellular subpopulation belonging to the CD4+ subset showed an HLA Dq. downregulation. The molecular constituents of the MHC Class II antigen expression characterizing cells belonging to other subsets remained unchanged. When the same stimulation assay was performed in the presence of a control medium (nulliparous serum), no changes concerning the MHC Class II molecular constituents were observed. When unrelated mononuclear cells were PHA stimulated in the presence of maternal and nulliparous serums, the HLA Dq. expression of the CD8+ subset showed a significant downregulation in the maternal serum mediated stimulation assay as compared to the control stimulation test. The molecular expression of the HLA Class II antigen related to the other subpopulations (CD4+, CD3+) stimulated by a mitogenic lectin remained unchanged. It is suggested that these molecular MHC Class II modulations are due to a factor included in the maternal IgG reaction. Retroplacental IgG contains the highest concentration of this factor.
近期免疫学术文献描述了一种胎盘后血清因子的存在,该因子负责下调MHC II类抗原的表达。在本报告中,在外周母体血清中也发现了同样的特性。然而,与胎盘后血清相比,外周母体血清存在时HLA II类调节活性降低,这表明类似IA的抑制因子在母胎界面释放。在母体血清池中对无关淋巴细胞进行三天的孵育期后,结果显示HLA Dr.、HLA Dp.,更显著的是HLA Dq.分子受到了调节。当在胎盘后血清存在的情况下,第三方淋巴细胞受到念珠菌素或无关单核细胞刺激时,只有属于CD4+亚群的细胞亚群显示出HLA Dq.下调。属于其他亚群的细胞中表征MHC II类抗原表达的分子成分保持不变。当在对照培养基(未生育妇女血清)存在的情况下进行相同的刺激试验时,未观察到与MHC II类分子成分有关的变化。当无关单核细胞在母体血清和未生育妇女血清存在的情况下受到PHA刺激时,与对照刺激试验相比,在母体血清介导的刺激试验中,CD8+亚群的HLA Dq.表达显示出显著下调。由促有丝分裂凝集素刺激的与其他亚群(CD4+、CD3+)相关的HLA II类抗原的分子表达保持不变。提示这些MHC II类分子调节是由于母体IgG反应中包含的一种因子所致。胎盘后IgG中该因子的浓度最高。